| Brokerage Reports (Showing 1 to 10 of 12) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 2-Feb-10 | Morgan Keegan & Company, Inc. | N/A | First Look - Feb 02 2010 07:55AM | 9 | $25 | | | View Abstract |
| 2-Feb-10 | Morgan Keegan & Company, Inc. | Lawrence S. Keusch | HAE: Although 3Q a bit light, 2011 should remain within long-term objectives | 12 | $25 | | | View Abstract |
| 29-Jan-10 | Morgan Keegan & Company, Inc. | Lawrence S. Keusch | BAX: Recall of Aquarius dialyzer not material, no change to estimates | 4 | $10 | | | View Abstract |
| 29-Jan-10 | Morgan Keegan & Company, Inc. | N/A | First Look - Jan 29 2010 08:00AM | 12 | $25 | | | View Abstract |
| 29-Jan-10 | Morgan Keegan & Company, Inc. | Lawrence S. Keusch | BAX: Attractive valuation with solid business fundamentals and R&D optionality | 12 | $25 | | | View Abstract |
| 19-Jan-10 | Morgan Keegan & Company, Inc. | N/A | First Look - Jan 19 2010 08:03AM | 6 | $25 | | | View Abstract |
| 19-Jan-10 | Morgan Keegan & Company, Inc. | Lawrence S. Keusch | Medical devices: 4Q earnings expected to be solid on the heels of FX | 7 | $25 | | | View Abstract |
| 14-Jan-10 | Morgan Keegan & Company, Inc. | N/A | First Look - Jan 14 2010 08:14AM | 7 | $25 | | | View Abstract |
| 14-Jan-10 | Morgan Keegan & Company, Inc. | Lawrence S. Keusch | BAX: Upgrading to Outperform based on our recent plasma survey and valuation | 13 | $50 | | | View Abstract |
| 12-Jan-10 | Thomson StreetEvents | N/A | BAX - Event Transcript of Baxter International Inc. conference call, Jan. 12, 2010 / 1:30pm ET | 7 | $75 | | | View Abstract |